UNSPSC 85816130: Introduction of high-dose interleukin-2 into peripheral artery, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of high-dose interleukin-2 into peripheral artery, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E05302

UNSPSC 85816130 Introduction of high-dose interleukin-2 into peripheral artery, percutaneous approach is a Commodity code describing a specific clinical procedure, yet recent state and local opportunities tagged under this code bear no meaningful connection to the procedure's clinical scope—instead reflecting a broad mix of health services procurement spanning telehealth urgent care, occupational health screening, EMS revenue billing, cancer registry services, and behavioral health programs. The code appears to function as a catch-all administrative taxonomy marker rather than a clinically coherent classification, and no state or local issuing body is actively procuring high-dose interleukin-2 therapy or the specific percutaneous arterial infusion procedure the code nominates.

The recent opportunities reveal substantial, active procurement across California, Georgia, Nevada, Colorado, Florida, Illinois, Kansas, Texas, Arizona, Missouri, Oregon, and the District of Columbia, with issuing bodies ranging from state health authorities and county health systems to municipal fire departments, school districts, and behavioral health agencies. Representative recent procurements include the Nevada Health Authority's RFP for Program of All Inclusive Care for the Elderly (PACE) operations across Nevada with proposals due December 10, 2026 (fixed capitation rates at 94 percent of actuarially developed rates ranging $4,532–$8,804 per participant monthly); San Mateo Medical Center's RFP for Cancer Registry Services due October 12, 2026 (approximately 1,000 annual cases, three-year term); the City of Ocala's RFP for Employee Health Clinic Services and Administration due April 20, 2026 (serving 2,950 eligible subscribers across five years with two optional renewals); and Sedgwick County and the City of Wichita's parallel RFPs for opioid use disorder treatment, prevention, and recovery services totaling $1.63 million in combined settlement funding with proposals due September 15, 2026. The code's continued misapplication to administrative healthcare contracting signals either systemic taxonomy misalignment in state and local procurement systems or a legacy data-quality issue; pursuit under this code carries low decision value unless your firm specializes in administering or operating the specific clinical interventions these opportunities actually solicit—which the code name does not reflect.